
Another milestone reached for AlzeCure’s Phase II clinical trial in neuropathic pain with non-opioid ACD440 22 June 2022
Uppsala Sweden, June 22st LINK Medical, the Northern European clinical research organization (CRO), and AlzeCure... Read more

Uppsala Sweden, June 22st LINK Medical, the Northern European clinical research organization (CRO), and AlzeCure... Read more

NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more

On Friday 6th May 2022 DANISH BIO – DANSK BIOTEK held its first Biotech Spring Gala; an amazing... Read more

NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more

May 2, 2022, LINK Medical and Serendipity Partners announce a new partnership. Serendipity Partners (Serendipity)... Read more
The SDG Business Accelerator is driven by the Ministry of Foreign affairs in partnership with a number... Read more

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more

Available to researchers and students at Danish research institutions for exploring opportunities for... Read more